The role of preeclampsia in breast cancer risk: insights from Mendelian randomization study

被引:0
|
作者
Qian, Chenfei [1 ]
Xiong, Ganwei [2 ]
Hong, Shihao [3 ]
Miao, Linzhe [1 ]
Guo, Yitao [1 ,4 ]
机构
[1] Zhejiang Hosp, Hangzhou 310013, Peoples R China
[2] First Peoples Hosp Xiushui Cty, Jiujiang 332400, Peoples R China
[3] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Obstet & Gynecol, Hangzhou 310016, Peoples R China
[4] Zhejiang Hosp, Dept Cardiol, Hangzhou 310013, Peoples R China
关键词
Preeclampsia; Breast cancer; Genome-wide association study; Mendelian randomization; Meta-analysis; ENDOTHELIAL-GROWTH-FACTOR; VEGF EXPRESSION; PREGNANCY; PATHOPHYSIOLOGY; ASSOCIATION; SERUM;
D O I
10.1007/s12672-025-02248-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The relationship between preeclampsia and breast cancer risk is still debated, with observational studies yielding inconsistent results. This research aims to clarify the causal link between preeclampsia and breast cancer using Mendelian randomization (MR) methods. Methods We utilized genome-wide association study (GWAS) data to identify single nucleotide polymorphisms (SNPs) that are significantly associated with preeclampsia, which served as genetic instruments. A two-sample Mendelian randomization (TSMR) approach was applied, primarily using inverse variance weighting (IVW) to assess the causal impact of preeclampsia on breast cancer risk. To strengthen our findings, a meta-analysis of IVW estimates from both discovery and validation cohorts was performed, complemented by sensitivity analyses to investigate heterogeneity and potential horizontal pleiotropy. Results In the discovery cohort, IVW analysis revealed a potential inverse relationship between preeclampsia and breast cancer risk (OR, 0.971; 95% CI, 0.947-0.996; P = 0.022). However, the validation cohort did not demonstrate a significant causal association (OR, 0.992; 95% CI, 0.975-1.008; P = 0.327). The combined meta-analysis indicated that preeclampsia might be linked to a lower risk of breast cancer (OR, 0.986; 95% CI, 0.972-0.999; P = 0.041). In subgroup analysis, preeclampsia was found to have a potential association only with estrogen receptor (ER)-negative breast cancer (OR, 0.956; 95% CI, 0.916-0.999; P = 0.043), while no significant link was observed with estrogen receptor (ER)-positive breast cancer (OR, 0.972; 95% CI, 0.945-1.000; P = 0.051). Sensitivity analyses indicated no significant heterogeneity or evidence of horizontal pleiotropy (P > 0.05). Conclusion This MR study, supported by a robust meta-analysis, suggests that preeclampsia may have a protective effect against breast cancer, especially ER-negative breast cancer. However, to firmly establish this relationship, additional prospective studies with larger populations are warranted. Moreover, further exploration of the biological mechanisms underlying this potential association is needed through both in vitro and in vivo research.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Inflammatory cytokines and their potential role in Sjogren's syndrome risk: insights from a mendelian randomization study
    Shi, Wenbin
    Xu, Yuli
    Zhang, Anan
    Jia, Xiqun
    Liu, Shuhua
    Hu, Ziyang
    ADVANCES IN RHEUMATOLOGY, 2024, 64 (01)
  • [22] Inflammatory cytokines and their potential role in Sjogren’s syndrome risk: insights from a mendelian randomization study
    Wenbin Shi
    Yuli Xu
    Anan Zhang
    Xiqun Jia
    Shuhua Liu
    Ziyang Hu
    Advances in Rheumatology, 64
  • [23] Diabetes and cancer risk: A Mendelian randomization study
    Goto, Atsushi
    Yamaji, Taiki
    Sawada, Norie
    Momozawa, Yukihide
    Kamatani, Yoichiro
    Kubo, Michiaki
    Shimazu, Taichi
    Inoue, Manami
    Noda, Mitsuhiko
    Tsugane, Shoichiro
    Iwasaki, Motoki
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (03) : 712 - 719
  • [24] Cathepsins and cancer risk: a Mendelian randomization study
    Deng, Tingting
    Lu, Xixue
    Jia, Xuemin
    Du, Jinxin
    Wang, Lijuan
    Cao, Baorui
    Yang, Meina
    Yin, Ying
    Liu, Fanjie
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [25] The Causal Effect of Dietary Composition on the Risk of Breast Cancer: A Mendelian Randomization Study
    Dong, Hao
    Kong, Xiangyi
    Wang, Xiangyu
    Liu, Qiang
    Fang, Yi
    Wang, Jing
    NUTRIENTS, 2023, 15 (11)
  • [26] The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study
    Johnson, Kelsey E.
    Siewert, Katherine M.
    Klarin, Derek
    Damrauer, Scott M.
    Program, Va Million Veteran
    Chang, Kyong-Mi
    Tsao, Philip S.
    Assimes, Themistocles L.
    Maxwell, Kara N.
    Voight, Benjamin F.
    PLOS MEDICINE, 2020, 17 (09)
  • [27] Identification of circulating metabolites linked to the risk of breast cancer: a mendelian randomization study
    Zhu, Xiaosheng
    Huang, Huai
    Zou, Mengjie
    Luo, Honglin
    Liu, Tianqi
    Zhu, Shaoliang
    Ye, Bin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [28] The Role of Genetically Determined Glycemic Traits in Breast Cancer: A Mendelian Randomization Study
    Jung, Su Yon
    Mancuso, Nicholas
    Han, Sihao
    Zhang, Zuo-Feng
    FRONTIERS IN GENETICS, 2020, 11
  • [29] Lipid metabolite levels associated with the risk of breast cancer: a Mendelian randomization study
    Zhang, W.
    Zhao, D.
    Huang, H.
    Uddin, H.
    Zhang, Y.
    Yang, H.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 116 - 117
  • [30] Sex hormone binding globulin and risk of breast cancer: a Mendelian randomization study
    Dimou, Niki L.
    Papadimitriou, Nikos
    Gill, Dipender
    Christakoudi, Sofia
    Murphy, Neil
    Gunter, Marc J.
    Travis, Ruth C.
    Key, Tim J.
    Fortner, Renee T.
    Haycock, Philip C.
    Lewis, Sarah J.
    Muir, Kenneth
    Martin, Richard M.
    Tsilidis, Konstantinos K.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2019, 48 (03) : 807 - 816